Zantac Users Patiently Await Answers About Zantac Cancer

Valisure testing pharmacy may have caused NDMA to increase by their testing

Wednesday, August 26, 2020 - Millions of people may suffer from anxiety of not understanding why and their popular drug has been recalled, and more importantly if their health has been compromised. Millions of heartburn sufferers were taking over the counter heartburn and acid reflux medication Zantac until the FDA issued a mandatory recall of the drug just a few months ago. People's worry has increased by the Coronavirus pandemic and the uncertainties that the situation has thrust on everyone.

The Food and Drug Administration (FDA) does not know why NDMA increases to carcinogenic levels. Preliminary research indicates it may be due to storing the medicine at a high temperature or in a humid environment. Exposing tablets to light may also cause NDMA to increase. The FDA has made getting to the bottom of the Zantac, NDMA mystery a top priority, and tests are currently underway. On April 1, 2020, the FDA recalled all packages of ranitidine and Zantac and has advised those that were using it to throw unused tablets in the garbage. The reason for the recall was that an independent researcher found Zantac tables tested had developed higher-than-normal levels of NDMA. According to the FDA, "FDA has found N-nitrosodimethylamine (NDMA) levels in some ranitidine products increase with time and temperature posing a risk to consumers, and therefore the agency has requested the withdrawal of all ranitidine products from the U.S. market." Heartburn sufferers are advised to improve their diet and lifestyle to help treat heartburn and acid reflux. If acid reflux persists one should seek the advice of their doctor as stomach acid leaching back up into the esophagus could cause esophageal cancer.

You could have developed one of many different types of cancer like stomach cancer, bladder, esophagus, prostate, breast, colon, or other from taking Zantac regularly over many years. Chances are if you have developed cancer, you will not know it until it is too late and nearly impossible to control. Cancer has a ten to twenty year latency period when it incubates inside a victim before symptoms of pain, lethargy, etc., present themselves and require a doctor's examination. It is good advice to see your doctor for a cancer screening if you were a regular Zantac user. Thousands of Zantac cancer victims have sought the guidance of a Zantac Cancer Lawyer to see if they qualify to file a claim against Sanofi, the maker of the world's best-selling antacid.

Sanofi is under investigation by the US Department of Justice of possibly lying to federal authorities about what they knew about NDMA in their medicine. Sanofi insists that they have taken proper precautions when they first heard about NDMA increases in Zantac and voluntarily withdrew the product from the market.

On the other hand, consumers that used Zantac may have nothing to worry about. Sanofi also claims that online testing pharmacy Valisure may have caused the increases in NDMA themselves in their testing process, an interesting twist to say the least.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.